Sep 5, 2008
Elan and Biogen Idec Initiate First Clinical Trial of TYSABRI(R) in Oncology
CAMBRIDGE, Mass. & DUBLIN, Ireland - Elan Corporation, plc and Biogen Idec today announced the initiation of the first clinical trial of TYSABRI in oncology.
Read full story from Earth Times
Comments
Please note by clicking on "Post Comment" you acknowledge that you have read the Terms of Service and the comment you are posting is in compliance with such terms. Be polite. Inappropriate posts may be removed by the moderator. Send us your feedback.
| Topic | Updated | Last By | Comments |
|---|---|---|---|
| Merck to fund Vioxx settlement in August | 1 hr | DJ -SMD | 1319 |
| MPI Research cutting jobs in Mattawan | 2 hr | Harold | 5 |
| Claims administrator: Interim payments in $4.85... | 3 hr | heraldo | 983 |
| Buffalo - The Next Cleveland? | 4 hr | Wow | 14 |
| Cymbalta leads the way for Lilly (from Feb '07) | 4 hr | edd | 232 |
| Vioxx claimants rush to join $4.85B settlement ... (from Jan '08) | 4 hr | IronLady | 647 |
| Teva Announces Launch of Generic Zoloft (from Nov '06) | 7 hr | KGH Monroe NC | 1113 |
Capricorn
Most Popular